20 articles
Scientists engineer high-PS procoagulant platelets that outperform thrombin and commercial hemostatic agents, even in antiplatelet-treated patients.
Comprehensive review reveals how PRP's growth factors, immune cells, and exosomes work together to enhance tissue repair across multiple medical specialties.
Comprehensive analysis reveals why platelet-rich plasma outcomes vary and provides framework for standardization.
Breakthrough chemical reprogramming method transforms ordinary blood cells into versatile stem cells without genetic modification.
New trial tests whether PRP injections can reduce tennis elbow pain better than standard treatments in 72 participants.
Small trial tests blood-derived therapy for persistent post-surgical ear infections that resist standard treatments.
A landmark clinical trial transplanted iPSC-derived dopamine neurons into Parkinson's patients using only tacrolimus — with no significant immune rejection.
Temperature-controlled plasma offers precise, minimally invasive treatment for laryngocele removal with improved surgical outcomes.
Review reveals progress in using stem cell-derived heart cells to treat heart failure, but survival and safety hurdles remain.
Autologous stem cell injections tested in patients with severe leg circulation problems who had no surgical options.
Dual stem cell therapy from fat tissue dramatically reduces limb amputation risk by rebuilding blood vessels in severe circulation disease.
New regenerative therapy combines platelet-rich plasma with biomaterial scaffolds to enhance wound repair through multiple healing pathways.
Military study tests regenerative PRP injections against placebo for facet joint pain in 91 participants.
Three days of GDF11 infusion post-injury preserved pericytes, protected the blood-spinal cord barrier, and improved functional recovery in mice.
150-person trial tests whether PRP injections can reduce knee pain and improve function better than placebo in osteoarthritis patients.
Japanese researchers develop minimally invasive method to transform T cells into glutamatergic neurons using just 5 factors.
Clinical trial tests platelet-rich plasma therapy for shoulder osteoarthritis in 91 patients over 5 months.
New research reveals how thrombopoietin hormone establishes lifelong blood stem cell hierarchy in newborns.
Packaging mitochondria in erythrocyte-derived membranes dramatically improves delivery efficiency, pushing this experimental therapy closer to clinical reality.
A review of iPSC-based regenerative medicine charts the path from Parkinson's disease models to real-world cell replacement therapies.
